Arsenal Biosciences
3 known investors
Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors. The company uses computational and engineering approaches to create cancer medicines.
BiotechHealthtechMedical Devices
Investors · 3
In the news
- Cell Therapy Company Arsenal Biosciences Implements Strategic Restructuring | PackGene Biotechpackgene.com · 2025
- UPDATED: ArsenalBio lays off 50% of staff in pivot from early-stage researchfiercebiotech.com · 2025
- ArsenalBio Raises $325M in Series C Fundingfinsmes.com · 2024
- ArsenalBio raises $325M for solid tumor CAR-T science with Regeneron and BMS in towfiercebiotech.com · 2024
- ArsenalBio raises $325M in one of the year’s largest biotech funding rounds | BioPharma Divebiopharmadive.com · 2024
- Arsenal Biosciences Raises $220M in Series B Financing | Precision Medicine Onlineprecisionmedicineonline.com · 2022